Results 201 to 210 of about 881,201 (350)

Early use of non‐vitamin K antagonist oral anticoagulants after cardiac surgery compared with warfarin for postoperative atrial fibrillation

open access: yesANZ Journal of Surgery, EarlyView.
With the increasing use of NOAC and the availability of reversal agents, there remains sparse evidence regarding its use in POAF. The use of a NOAC in patients with POAF did not appear to increase short‐term postoperative complications, including bleeding, stroke, readmission rates and mortality, compared with warfarin.
Shantel Chang   +5 more
wiley   +1 more source

Perioperative Mechanical Circulatory Support for Cardiac Assistance in Thoracic Surgery: A Scoping Review

open access: yesArtificial Organs, EarlyView.
High‐risk cardiac patients may benefit from timely temporary mechanical circulatory support (tMCS) implantation to provide perioperative hemodynamic stabilization and circulatory support, thus enabling them to undergo life‐saving thoracic surgery. CPB: cardiopulmonary bypass; IABP: intra‐aortic balloon pump; tMCS: temporary mechanical circulatory ...
Viviana Teresa Agosta   +4 more
wiley   +1 more source

Mixed Cardiogenic-Vasodilatory Shock

open access: yesJACC: Advances
This state-of-the-art review describes the potential etiologies, pathophysiology, and management of mixed shock in the context of a proposed novel classification system.
Jacob C. Jentzer, MD   +9 more
doaj  

Coronary Artery Bypass Grafting on Microaxial Flow Pump Support in Patients With Severely Reduced Left Ventricular Ejection Fraction

open access: yesArtificial Organs, EarlyView.
Coronary artery revascularization with microaxial flow pump support in patients with severely reduced left ventricular ejection fraction is an emerging technique in cardiac surgery. In this manuscript, we present early results, highlight the advantages, and discuss the key limitations of this approach.
Gaik Nersesian   +9 more
wiley   +1 more source

Hemoglobin in cardiogenic shock: the lower, the poorer survival. [PDF]

open access: yesJ Intensive Care
Cherbi M   +13 more
europepmc   +1 more source

-50-METABOLIC CHANGES IN NON-ISCHEMIC MYOCARDIUM IN CARDIOGENIC SHOCK COMPLICATED IN ACUTE MYOCARDIAL INFARCTION

open access: bronze, 1986
Mamoru Mochizuki   +8 more
openalex   +2 more sources

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen   +3 more
wiley   +1 more source

The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis

open access: bronze, 1994
Pedro R. Moreno   +4 more
openalex   +1 more source

The Effect of Early IABP and Reperfusion therapy in Patient of Post MI Cardiogenic shock [PDF]

open access: bronze, 2000
Jong-Suk Lee   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy